Resistance to Immunotherapeutic Antibodies in Cancer

Summarizes common and unique features of mAbs against various cancers Explores the latest developments on the molecular, biochemical and genetic mechanisms of resistance by various mAbs Covers the potential use of the combination treatment of mAbs with other drugs/mAbs to reverse resistance Includes supplementary material: sn.pub/extras